- Messages
- 7,648
- Reaction score
- 997
- Points
- 278
Britain:
www.economist.com
... Under a new policy that enters force on January 31st, valproate will be off-limits to all new patients under 55, unless two specialists agree that nothing else will work. Later this year, those already on it will need a second opinion to retain their prescription.
...
The question is whether the people who need valproate—often the ones with the most dangerous seizures—will get timely treatment. Their doctors may be caught between following the MHRA’s rules and respecting people’s well-informed choices.
Valproate is not alone. The MHRA is reviewing topiramate, another anti-seizure medicine, for its effects on fetuses. Several other drugs also carry heightened risks. Doctors will have difficult calls to make. Lawyers are paying close attention.

The ethical quagmire of a fetus-harming epilepsy drug
Britain is restricting the use of valproate. Charities are alarmed